|本期目录/Table of Contents|

[1]耿莉莉,杜雪.子宫内膜息肉恶变的临床因素分析及宫腔镜下特征性差异[J].天津医科大学学报,2021,27(04):392-395,430.
 GENG Li-li,DU Xue.Clinical factors analysis of endometrial polyps malignancy and characteristic difference under hysteroscopy[J].Journal of Tianjin Medical University,2021,27(04):392-395,430.
点击复制

子宫内膜息肉恶变的临床因素分析及宫腔镜下特征性差异(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年04期
页码:
392-395,430
栏目:
临床医学
出版日期:
2021-07-20

文章信息/Info

Title:
Clinical factors analysis of endometrial polyps malignancy and characteristic difference under hysteroscopy
文章编号:
1006-8147(2021)04-0392-05
作者:
耿莉莉杜雪
(天津医科大学总医院妇产科,天津 300052)
Author(s):
GENG Li-liDU Xue
(Department of Obstetrics and Gynecology,General Hospital,Tianjin Medical University,Tianjin 300052,China)
关键词:
子宫内膜息肉恶变绝经期危险因素宫腔镜
Keywords:
endometrial polyps malignant transformation menopause risk factors hysteroscopy
分类号:
R711.74
DOI:
-
文献标志码:
A
摘要:
目的:探讨子宫内膜息肉(EP)患者的临床特点及宫腔镜下特征性差异,预测EP恶变的危险因素。方法:回顾性分析2016年1月—2019年12月天津医科大学总医院收治的EP患者684例,依据病理结果分为良性EP组655例,平均年龄(44.0±12.6)岁;恶性EP组29例,平均年龄(54.2±13.1)岁;对两组患者的临床特点及宫腔镜检查结果进行统计分析。结果:良性组与恶性组间年龄、体重指数、子宫不规则出血、绝经期、EP直径≥2 cm、EP合并宫颈病变、EP表面出血、EP表面血供丰富及表面形态不规则差异有统计学意义(t=-4.266、-5.038,χ2=11.821、12.450、31.400、38.226、22.514、154.753、53.867,均P<0.05);二元Logistic分析显示,绝经期(OR=2.462,95%CI:1.114~5.442)、超重(OR=1.211,95%CI:1.116~1.314)、子宫不规则出血(OR=5.147,95%CI:1.256~21.096)、EP直径≥2 cm(OR=1.592,95%CI:1.172~2.164)、EP表面血供丰富(OR=24.209,95%CI: 6.281~93.307)及EP表面形态不规则(OR=8.272,95%CI:2.038~33.580)与EP恶变显著相关(均P<0.05)。结论:绝经期、超重、子宫不规则出血、EP直径≥2 cm、EP表面血供丰富以及EP表面形态不规则为EP恶变的危险因素,临床特点和宫腔镜下EP的特征性差异能很好预测EP的良、恶性。
Abstract:
Objective: To investigate the clinical characteristics and hysteroscopic differences of endometrial polyps(EP)patients,and to predict the risk factors for the malignant degeneration of EP. Methods: Retrospective analysis was performed on 684 patients with EP who were admitted to General Hospital of Tianjin Medical University from January 2016 to December 2019. According to the pathological results,all the patients were divided into benign EP group[n=655,an average age of (44.0±12.6) years] and malignant EP group [n=29,an average age of(54.2±13.1)years].The clinical characteristics and hysteroscopy results between the two groups were statistically analyzed. Results: Age,body mass index,irregular uterine bleeding,menopause,diameter of EP≥2 cm,EP complicated with cervical lesions,EP surface bleeding,EP surface blood supply and irregular surface morphology between benign group and malignant group(t=-4.266,-5.038,χ2=11.821,12.450,31.400,38.226,22.514,154.753,53.867,all P<0.05) have statistical significance;the binary Logistic analysis showed that menopause(OR=2.462,95%CI:1.114-5.442),overweight(OR=1.211,95%CI:1.116-1.314),irregular uterine bleeding(OR=5.147,95% CI:1.256-21.096),diameter of EP≥2 cm(OR=1.592,95%CI:1.172-2.164),abundant EP surface blood supply(OR=24.209,95%CI:6.281-93.307)and irregular surface morphology of EP(OR=8.272,95%CI:2.038-33.580)were significantly associated with malignant degeneration of EP. Conclusion: Menopause,overweight,irregular uterine bleeding, diameter of EP≥2 cm,abundant blood supply on EP surface and irregular surface morphology are the risk factors related with malignant degeneration of EP,so the clinical characteristics and the characteristic differences of hysteroscopic EP can well predict the benign and malignant of EP.

参考文献/References:

[1] Bakour S H,Khan K S,Gupta J K. The risk of premalignant and malignant pathology in endometrial polyps[J]. Acta Obstet Gynecol Scand,2002,81(2):182
[2] Pergialiotis V,Prodromidou A,Siotos C,et al. Systemic hypertension and diabetes mellitus as predictors of malignancy among women with endometrial polyps: a meta-analysis of observational studies[J]. Menopause,2016,23(6):691
[3] Wang J H,Zhao J,Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies[J]. J Minim Invasive Gynecol,2010,17(1):53
[4] Ozer A,Ozer S,Kanat-Pektas M. Correlation between transvaginal ultrasound measured endometrial thickness and histopathological findings in Turkish women with abnormal uterine bleeding[J]. J Obstet Gynaecol Res,2016,42(5):573
[5] Uglietti A,Mazzei C,Deminico N,et al. Endometrial polyps detected at ultrasound and rate of malignancy[J]. Arch Gynecol Obstet,2014, 289(4):839
[6] Gkrozou F,Dimakopoulos G,Vrekoussis T,et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies[J]. Arch Gynecol Obstet,2015,291(6):1347
[7] Di Spiezio S A,Calagna G,Guida M,et al. Hysteroscopy and treatment of uterine polyps[J]. Best Pract Res Clin Obstet Gynaecol,2015, 29(7):908
[8] Pereira A K,Garcia M T,Pinheiro W,et al. What is the influence of cyclooxygenase-2 on postmenopausal endometrial polyps?[J]. Climacteric,2015,18(4):498
[9] 覃丽渊,孙燕. PTEN、PI3K、AKT蛋白在子宫内膜息肉中的表达及意义[J]. 广东医学,2018,39(9):1369
[10] Ricciardi E,Vecchione A,Marci R,et al. Clinical factors and malignancy in endometrial polyps. Analysis of 1027 cases[J]. Eur J Obstet Gynecol Reprod Biol,2014,183:121
[11] Baiocchi G,Manci N,Pazzaglia M,et al. Malignancy in endometrial polyps:a 12-year experience[J]. Am J Obstet Gynecol,2009, 201(5):461
[12] Ferrazzi E,Zupi E,Leone F P,et al. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study[J]. Am J Obstet Gynecol,2009,200(3):231
[13] Cohen I. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy[J]. Maturitas,2008,59(1):99
[14] Gregoriou O,Konidaris S,Vrachnis N,et al. Clinical parameters linked with malignancy in endometrial polyps[J]. Climacteric,2009, 12(5):454
[15] Serhat E,Cogendez E,Selcuk S,et al. Is there a relationship between endometrial polyps and obesity,diabetes mellitus,hypertension?[J]. Arch Gynecol Obstet,2014,290(5):937
[16] Nappi L,Indraccolo U,Di Spiezio S A,et al. Are diabetes,hypertension,and obesity independent risk factors for endometrial polyps?[J]. J Minim Invasive Gynecol,2009,16(2):157
[17] Sasaki L,Andrade K,Figueiredo A,et al. Factors associated with malignancy in hysteroscopically resected endometrial polyps: asystematic review and meta-analysis[J]. J Minim Invasive Gynecol,2018, 25(5):777
[18] Wethington S L,Herzog T J,Burke W M,et al. Risk and predictors of malignancy in women with endometrial polyps[J]. Ann Surg Oncol,2011,18(13):3819
[19] Lasmar B P,Lasmar R B. Endometrial polyp size and polyp hyperplasia[J]. Int J Gynaecol Obstet,2013,123(3):236
[20] Shor S,Pansky M,Maymon R,et al. Prediction of premalignant and malignant endometrial polyps by clinical and hysteroscopic features[J]. J Minim Invasive Gynecol,2019,26(7):1311
[21] Ngo Y G,Fu H C,Chu L C,et al. Specific hysteroscopic findings can efficiently distinguish the differences between malignant and benign endometrial polyps[J]. Taiwan J Obstet Gynecol,2020,59(1):85
[22] Ben-Arie A,Goldchmit C,Laviv Y,et al. The malignant potential of endometrial polyps[J]. Eur J Obstet Gynecol Reprod Biol,2004, 115(2):206
[23] Daniele A,Ferrero A,Maggiorotto F,et al. Suspecting malignancy in endometrial polyps: value of hysteroscopy[J]. Tumori,2013,99(2):204
[24] Jacobs I,Tibosch R,Geomini P,et al. Atypical endometrial polyps and the incidence of endometrial cancer: a retrospective cohort study[J]. BJOG,2020,127(8):994
[25] Sheng K K,Lyons S D. To treat or not to treat? An evidence-based practice guide for the management of endometrial polyps[J]. Climacteric,2020,23(4):336
[26] Karakas L A,Atilgan A O,Akilli H,et al. Nulliparity and postmenopausal status are independent factors of malignancy potential of endometrial intraepithelial neoplasia in polyps[J]. Int J Gynaecol Obstet,2021,152(3):433

相似文献/References:

[1]吴桃,呼学敏,杨玉芳,等.基于生物信息学分析探讨子宫内膜异位症恶变的机制[J].天津医科大学学报,2023,29(04):366.
 WU Tao,HU Xue-min,YANG Yu-fang,et al.Exploring the mechanism of malignant transformation of endometriosis based on bioinformatics analysis[J].Journal of Tianjin Medical University,2023,29(04):366.

备注/Memo

备注/Memo:
作者简介:耿莉莉(1985-),女,主治医师,硕士在读,研究方向:妇科内分泌;通信作者:杜雪,E-mail:duxue@tmu.edu.cn。
更新日期/Last Update: 2021-07-25